Merit Medical Systems, Inc. Profile Avatar - Palmy Investing

Merit Medical Systems, Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company opera…
Medical - Instruments & Supplies
US, South Jordan [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
42.26 43.30 46.03 46.16 43.28 44.19 43.49 43.89 44.82 44.72 43.46 41.62 45.16 45.10 41.67
Profit Margin
8.75 4.20 6.41 5.00 3.69 4.51 4.39 3.33 3.78 4.76 0.55 -1.02 4.51 6.47 7.53
Operating Margin
12.76 5.80 9.23 7.52 6.20 7.88 6.92 5.78 4.54 6.64 -6.60 -6.49 5.67 7.61 9.73
EPS Growth
6.67 -45.31 68.57 -20.34 -17.02 35.90 1.89 -16.67 24.44 42.86 -87.63 -281.82 577.78 52.33 25.19
Return on Assets (ROA)
8.30 3.37 5.16 2.79 2.28 3.07 3.06 2.13 2.48 2.59 0.31 -0.59 2.94 4.48 4.06
Return on Equity (ROE)
10.30 5.28 6.45 5.17 4.08 5.28 5.11 4.04 4.07 4.50 0.57 -1.03 4.66 6.51 7.85
Return on Invested Capital (ROIC)
9.89 4.02 6.00 3.42 3.55 4.43 4.25 3.36 2.66 3.75 -11.08 -3.34 4.04 5.59 5.04
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
2.71 22.04 6.88 33.68 34.17 30.05 26.66 34.41 25.05 24.39 29.80 26.14 19.11 16.15 35.92
Debt/Equity
3.36 34.54 8.61 62.26 61.34 51.58 44.54 65.11 41.17 42.36 55.14 45.39 30.30 23.48 69.48
Debt/EBITDA
2.63 304.13 52.63 742.85 757.25 530.49 528.23 879.39 544.25 541.97 1,240.47 854.75 143.40 108.05 135.39
Debt/Capitalization
3.25 25.67 7.93 38.37 38.02 34.03 30.81 39.43 29.17 29.76 35.54 31.22 23.25 19.02 40.99
Interest Debt per Share USD
0.21 2.33 0.81 5.65 6.03 5.41 4.86 7.50 5.86 7.76 9.74 8.03 5.70 4.84 14.81
Debt Growth
1,802.17 1,064.83 -62.30 672.90 4.75 -9.79 -7.53 56.25 -14.15 41.90 32.54 -16.93 -27.59 -14.69 231.67
Liquidity
Current Ratio
277.00 279.52 314.67 218.67 256.81 254.99 232.06 275.58 273.41 245.14 250.22 232.27 204.08 239.79 544.53
Quick Ratio
118.19 110.80 130.38 90.49 110.74 116.54 93.72 119.73 128.45 123.95 117.17 116.15 101.82 107.35 383.12
Cash Ratio
18.64 9.30 23.85 13.12 11.55 9.75 4.75 21.70 27.97 38.42 24.40 30.76 28.67 26.47 289.41
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
315.16 277.67 277.47 250.94 309.16 309.97 289.03 280.72 258.62 247.04 249.22 284.16 265.60 237.56 240.58
Receivables Turnover
785.88 727.68 794.35 687.88 700.69 632.75 693.17 697.38 626.51 588.56 590.31 610.19 621.82 645.00 662.20
Payables Turnover
1,113.39 837.43 853.53 612.92 960.67 954.27 806.72 1,106.55 1,149.69 903.27 1,029.76 1,129.08 1,059.65 922.40 1,108.59
Asset Turnover
94.82 80.22 80.41 55.90 61.66 68.22 69.62 64.05 65.47 54.49 56.61 57.91 65.20 69.17 53.90
Coverage
Interest Coverage
117,310.71 2,886.58 4,206.59 4,907.45 346.15 454.93 602.71 396.41 427.47 565.80 -529.34 -626.13 1,157.88 1,381.34 675.10
Asset Coverage
3,100 300 1,100 200 200 200 200 200 200 200 200 200 300 400 200
Cash Flow Coverage (CFGR)
409.45 42.63 110.66 19.76 20.64 23.75 33.46 16.52 22.53 21.90 14.86 37.99 46.74 42.53 17.38
EBITDA Coverage
117,900 4,200 4,900 5,000 300 400 600 300 500 500 300 400 3,200 3,000 1,200
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
4.18 2.79 4.41 3.36 2.47 3.07 2.91 1.71 1.31 1.44 0.32 -0.32 1.39 1.86 2.16
Price/Earnings (P/E)
2,392.06 3,586.78 2,269.44 2,974.36 4,047.28 3,254.41 3,439.33 5,848.68 7,660.41 6,942.61 31,543.60 -31,262.23 7,218.87 5,383.60 4,633.74
Price/Book (P/B)
246.30 189.32 146.45 153.64 165.30 171.78 175.63 236.22 311.74 312.73 181.00 321.01 336.40 350.55 363.96
Price/Sales (P/S)
209.32 150.60 145.49 148.68 149.35 146.69 151.00 194.89 289.67 330.45 172.83 319.25 325.46 348.54 349.06
Price/Cash Flow (P/CF)
1,792.26 1,285.71 1,537.47 1,248.98 1,305.42 1,402.10 1,178.60 2,195.59 3,361.19 3,371.06 2,209.71 1,861.89 2,375.75 3,510.02 3,013.94
End of MMSI's Analysis
CIK: 856982 CUSIP: 589889104 ISIN: US5898891040 LEI: - UEI: -
Secondary Listings
MMSI has no secondary listings inside our databases.